References
- Thomson Micromedex. Micromedex Healthcare Series. USA: Thomson Micromedex, (1974–2006).
- A Jaeger, F Jehl, and F Flesch. Toxicokinetics of alpha and beta amanitins in Amanita phalloides poisoning. Communication: XII Congress of EAPCC, Bruxelles, Belgium, (1988); 27–30.
- A Jaeger, F Jehl, and F Flesch. (1993). Kinetics of amatoxins in human poisoning: therapeutic implications. Clin Toxicol 31 (1):63–80.
- HG Bivins, R Bivins, R Lammers, DB McMicken, and O Wolowodiuk. (1985). Mushroom ingestion. Ann Emerg Med 14:101–106.
- M Genzert, N Felenhauer, and T Zilker. (2005). Indication of liver transplantation following amatoxin intoxication. J Hepatol 42:202–209.
- TI Huo, JC Wu, WY Sheng, CY Chan, SJ Hwang, TZ Chen, and SD Lee. (1996). Prognostic factor analysis of fulminant hepatic failure in an area endemic for hepatitis. J Gastroenterol Hepatol 11 (6):560–565.
- JG O'Grady, GJ Alexander, KM Hayllar, and R Williams. (1989). Early indicators of prognosis in fulminant hepatic failure. J Gastroenterol Hepatol 97 (2):439.
- J Polson, and WM Lee. (2005). AASLD position paper: the management of acute liver failure. Hepatology 41 (5):1179–1197.
- A Armuzzi, M Candelli, MA Zocco, A Andreoli, A De Lorenzo, EC Nista, L Fini, L Miele, F Cremonini, IA Cazzato, A Grieco, G Gasbarrini, and A Gasbarrini. (2002). Breath testing for human liver function assessment. Aliment Pharmacol Ther 16:1977–1996.
- M Becker. (1998). 13C breath tests for measurement of liver function. Gut 43 (3):25–27.
- B Braden, D Faust, U Sarrazin, S Zeuzem, CF Dietrich, WF Caspary, and C Sarrazin. (2005). 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 21 (2):179–185.
- D Festi, S Capodicasa, L Sandri, L Colaiocco-Ferrante, E Staniscia, A Vestito, P Simoni, G Mazzella, P Portincasa, E Roda, and A Colecchia. (2005). Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child–Pugh score and serum bile acid levels. World J Gastroenterol 11 (1):142–148.
- H Fischer, and K Wetzel. (2002). The future of 13C-breath tests. Food Nutr Bull 23 (3):53–56.
- S Klatt, C Taut, D Mayer, G Adler, and K Beckh. (1997). Evaluation of the 13C-methacetin breath test for quantitative liver function testing. Z Gastroenterol 35 (8):609–614.
- S Lara-Baruque, M Razquin, I Jimenez, A Vazquez, JP Gisbert, and JM Pajares. (2000). 13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease. Dig Liver Dis 32 (3):226–232.
- EC Nista, L Fini, A Armuzzi, M Candelli, MA Zocco, IA Cazzato, G Merra, R Finizio, L Miele, A Grieco, G Gasbarrini, and A Gasbarrini. (2004). 13C-breath tests in the study of microssomal function. Eur Rev Med Pharmacol Sci 8:33–46.
- H Shrin, V Aeed, and M Sori. (2006). Utility of methacetin breath test in the evaluation of the extent of hepatic injury in an animal model. Gastroenterology 130:A828.
- A Petrolati, D Festi, G De Berardinis, L Colaiocco-Ferrante, D Di Paolo, G Tisone, and M Angelico. (2003). 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther 18 (8):785–790.
- G Haycock, G Schwartz, and D Wisotsky. (1978). Geom for measuring body surface area. J Pediatr 93:62–66.
- RR Sokal, and FJ Rhalf. Biometry, the Principles and Practice of Statistics in Biological Research. NY, USA: W.H. Freeman and Company, (1998).
- JG Lim, JH Kim, and CY Lee. (2000). Amanita virosa induced toxic hepatitis: report of three cases. Yonsei Med J 41:416–421.
- B Pfaffenbach, O Gotze, C Szymanski, D Hagemann, and RJ Adamek. (1998). The 13C-methacetin breath test for quantitative noninvasive liver function analysis with an isotope-specific nondispersive infrared spectrometer in liver cirrhosis. Dtsch Med Wochenschr 123 (49):1467–1471.